Nexavar Granted FDA Priority Review for Treatment of Liver Cancer - CNNMoney.com
Nexavar Granted FDA Priority Review for Treatment of Liver CancerCNNMoney.com - Aug 20, 2007HCC, the most common form of liver cancer, is responsible for about 90 percent of the primary malignant liver tumors in adults.(1,2) Liver cancer is the …
Read full story